Ghana vs Papua New Guinea: Protecting minority investors: Strength of minority investor
Ghana
30 DB15-20 methodology
in 2019
Papua New Guinea
30 DB15-20 methodology
in 2019
Ghana rank
72nd
Papua New Guinea rank
72nd
Protecting minority investors: Strength of minority investor over time
- Ghana
- Papua New Guinea
How they compare
Ghana currently reports 30 DB15-20 methodology against 30 DB15-20 methodology in Papua New Guinea, a difference of 0 DB15-20 methodology.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was Ghana ahead.
Ghana ranks 72nd and Papua New Guinea ranks 72nd of 191 countries.
Ghana has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: strength of minority investor, Ghana or Papua New Guinea?
- Ghana, at 30 DB15-20 methodology against 30 DB15-20 methodology in Papua New Guinea as of 2019.
- What is the difference in protecting minority investors: strength of minority investor between Ghana and Papua New Guinea?
- 0 DB15-20 methodology, with Ghana ahead.
- How many years of comparable data are there for Ghana and Papua New Guinea?
- 7 years are reported by both, from 2013 to 2019.
- How do Ghana and Papua New Guinea rank globally for protecting minority investors: strength of minority investor?
- Ghana ranks 72nd and Papua New Guinea ranks 72nd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Strength of minority investor protection index (0-50) (DB15-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The strength of minority investor protection index is the sum of the extent of disclosure index, extent of director liability index, ease of shareholder suits index, extent of shareholder rights index, extent of ownership and control index and extent of corporate transparency index. The index is computed based on the methodology in the DB15-20 studies.